Aspire Biopharma Holdings (ASBP) Enterprise Value (2022 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Enterprise Value came in at -$1.8 million in Q1 2026, down 35.66% year-on-year from -$2.8 million in Q1 2025, and down 35.66% on a QoQ basis from -$1.3 million in Q1 2025.
Aspire Biopharma Holdings (ASBP) Enterprise Value (2022 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 5 years of Enterprise Value data on file, last reported at -$1.8 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 35.66% year-over-year to -$1.8 million in Q1 2026; TTM through Mar 2026 was -$1.8 million, a 35.66% decrease from a year earlier, with the FY2024 full-year figure at -$3633.0, up 67.49% from the prior year.
- Enterprise Value for Q1 2026 stood at -$1.8 million, down from -$1.3 million in the prior quarter.
- Over the last five years, Enterprise Value for ASBP reached as high as -$3633.0 in Q4 2024 and fell as low as -$1.8 million in Q1 2026.
- Historically, Enterprise Value has averaged -$484578.2 across 5 years, with a median of -$406205.5 in 2022.
- Across the five-year window, Enterprise Value soared 97.75% in 2023 and tumbled 2747.6% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$497259.0 in 2022, then surged by 97.75% to -$11174.0 in 2023, then soared by 67.49% to -$3633.0 in 2024, then slumped by 36964.22% to -$1.3 million in 2025, then sank by 35.66% to -$1.8 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$1.8 million in Q1 2026, -$1.3 million in Q1 2025, and -$3633.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | Aspire Biopharma Holdings | 1.09 Mn | -733,865.14 | 5,750.00 | -1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.83 Mn |
| Mar 31, 2025 | -1.35 Mn |
| Dec 31, 2024 | -3,633.00 |
| Sep 30, 2024 | -16,541.00 |
| Jun 30, 2024 | -19,604.00 |
| Mar 31, 2024 | -47,287.00 |
| Dec 31, 2023 | -11,174.00 |
| Mar 31, 2023 | -315,152.00 |
| Dec 31, 2022 | -497,259.00 |
| Sep 30, 2022 | -533,129.00 |
| Jun 30, 2022 | -579,751.00 |
| Mar 31, 2022 | -618,122.00 |